Patricia M. Barlow

The Development and Validation of the Norfolk QOL-DN, a New Measure of Patients' Perception of the Effects of Diabetes and Diabetic Neuropathy

Etta J. Vinik, Risa P. Hayes, Alan Oglesby et al. · Diabetes Technology & Therapeutics · 2005 · 235 citations

A 6-Month, Randomized, Double-Masked, Placebo-Controlled Study Evaluating the Effects of the Protein Kinase C-β Inhibitor Ruboxistaurin on Skin Microvascular Blood Flow and Other Measures of Diabetic Peripheral Neuropathy

Carolina Casellini, Patricia M. Barlow, Amanda L. Rice et al. · Diabetes Care · 2007 · 129 citations

Small Fiber Neuropathy Is Associated with the Metabolic Syndrome

Gary L. Pittenger, Anahit Mehrabyan, Kathryn Simmons et al. · Metabolic Syndrome and Related Disorders · 2005 · 118 citations

Rosiglitazone treatment increases nitric oxide production in human peripheral skin

Aaron I. Vinik, Kevin B Stansberry, Patricia M. Barlow · Journal of Diabetes and its Complications · 2003 · 45 citations

Reactive Nitrogen Specie, Medicine, Human Peripheral Skin +5

Pioglitazone Treatment Improves Nitrosative Stress in Type 2 Diabetes

Aaron I. Vinik, Jagdeesh Ullal, Henri K. Parson et al. · Diabetes Care · 2006 · 21 citations · Full text